Drug profile · INN
esomeprazole sodium
ESOMEPRAZOLE SODIUM
esomeprazole sodium (ESOMEPRAZOLE SODIUM) is a potassium-transporting atpase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — esomeprazole sodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
esomeprazole sodium (ESOMEPRAZOLE SODIUM) is a potassium-transporting atpase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium-transporting ATPase inhibitor
Primary target: Potassium-transporting ATPase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is esomeprazole sodium?
esomeprazole sodium (ESOMEPRAZOLE SODIUM) is a potassium-transporting atpase inhibitor. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for esomeprazole sodium?
ESOMEPRAZOLE SODIUM is a marketed brand name for esomeprazole sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of esomeprazole sodium?
esomeprazole sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.